Trial Profile
A Multicenter, Randomized, Prospective, Double-Blind Study to Evaluate the Nephroprotective Effect of Delapril Alone or Combined With Manidipine in Patients With Type 2 Diabetes
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Mar 2022
Price :
$35
*
At a glance
- Drugs Delapril (Primary) ; Delapril/manidipine (Primary)
- Indications Diabetic nephropathies; Hypertension
- Focus Therapeutic Use
- Acronyms DEMAND
- 01 Mar 2022 Results of sub-group analysis of changes in glomerular hemodynamic parameters, published in the Acta Diabetologica.
- 24 Jan 2008 Status changed from in progress to completed.
- 21 Dec 2007 New trial record.